SE9303444D0 - New use of prostaglandins - Google Patents

New use of prostaglandins

Info

Publication number
SE9303444D0
SE9303444D0 SE9303444A SE9303444A SE9303444D0 SE 9303444 D0 SE9303444 D0 SE 9303444D0 SE 9303444 A SE9303444 A SE 9303444A SE 9303444 A SE9303444 A SE 9303444A SE 9303444 D0 SE9303444 D0 SE 9303444D0
Authority
SE
Sweden
Prior art keywords
prostaglandins
new use
prostaglandin
analogues
derivatives
Prior art date
Application number
SE9303444A
Other languages
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9303444A priority Critical patent/SE9303444D0/sv
Publication of SE9303444D0 publication Critical patent/SE9303444D0/sv
Priority to JP7511697A priority patent/JPH09504021A/ja
Priority to EP94931257A priority patent/EP0724425A1/en
Priority to PCT/SE1994/000985 priority patent/WO1995011003A1/en
Priority to CA002174655A priority patent/CA2174655A1/en
Priority to AU80086/94A priority patent/AU8008694A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
SE9303444A 1993-10-20 1993-10-20 New use of prostaglandins SE9303444D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9303444A SE9303444D0 (sv) 1993-10-20 1993-10-20 New use of prostaglandins
JP7511697A JPH09504021A (ja) 1993-10-20 1994-10-19 プロスタグランジンの新規使用
EP94931257A EP0724425A1 (en) 1993-10-20 1994-10-19 New use of prostaglandins
PCT/SE1994/000985 WO1995011003A1 (en) 1993-10-20 1994-10-19 New use of prostaglandins
CA002174655A CA2174655A1 (en) 1993-10-20 1994-10-19 New use of prostaglandins
AU80086/94A AU8008694A (en) 1993-10-20 1994-10-19 New use of prostaglandins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303444A SE9303444D0 (sv) 1993-10-20 1993-10-20 New use of prostaglandins

Publications (1)

Publication Number Publication Date
SE9303444D0 true SE9303444D0 (sv) 1993-10-20

Family

ID=20391475

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303444A SE9303444D0 (sv) 1993-10-20 1993-10-20 New use of prostaglandins

Country Status (6)

Country Link
EP (1) EP0724425A1 (sv)
JP (1) JPH09504021A (sv)
AU (1) AU8008694A (sv)
CA (1) CA2174655A1 (sv)
SE (1) SE9303444D0 (sv)
WO (1) WO1995011003A1 (sv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3588797A (en) * 1996-07-03 1998-01-21 Board Of Regents Of The University Of Oklahoma, The Enhancement of skin pigmentation by prostaglandins
WO1998033497A1 (en) 1997-02-04 1998-08-06 Johnstone Murray A Method of enhancing hair growth
PL350917A1 (en) 1999-03-05 2003-02-10 Procter & Gamble C16 unsaturated fp-selective prostaglandins analogs
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
FR2812190B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
KR100437873B1 (ko) 2001-05-08 2004-06-26 연성정밀화학(주) 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
JP4584908B2 (ja) 2003-02-12 2010-11-24 ロレアル 皮膚または皮膚付属物の色素沈着を刺激するための１５−ヒドロキシプロスタグランジンデヒドロゲナーゼの阻害剤の使用
US7326717B2 (en) 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
TWI348386B (en) 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
FR2907682B1 (fr) 2006-10-26 2012-12-07 Vincience Composition cosmetique et/ou pharmaceutique comprenant comme principe actif au moins un peptide et utilisation de ce peptide.
FR2920309B1 (fr) 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
WO2010027040A1 (ja) * 2008-09-04 2010-03-11 参天製薬株式会社 １５，１５－ジフルオロプロスタグランジンＦ2α誘導体を有効成分として含有する毛髪成長促進剤
WO2010064203A1 (en) 2008-12-02 2010-06-10 L'oreal Combination of reduced glutathione and amino acids for improving the quality of the hair in women
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
FR2949052B1 (fr) 2009-08-13 2015-03-27 Oreal Procede de traitement cosmetique du cuir chevelu.
FR2951938B1 (fr) 2009-10-30 2012-01-06 Oreal Utilisation d'un extrait de punica granatum pour lutter contre la canitie
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
BR122017013201B1 (pt) 2009-11-09 2018-05-15 Allergan, Inc. Composição para a estimulação de crescimento capilar
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
FR2978659B1 (fr) 2011-08-05 2014-01-10 Oreal Utilisation de composes cannabinoides pour stimuler la melanogenese
AU2013249434B2 (en) 2012-04-16 2017-10-12 Board Of Regents Of The University Of Texas System Compositions and methods of modulating 15-PGDH activity
FR2999932B1 (fr) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999931A1 (fr) 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
AU2014342811B2 (en) 2013-10-15 2019-01-03 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
CN107921025A (zh) 2015-03-08 2018-04-17 卡斯西部储备大学 用于治疗纤维症的短链脱氢酶活性的抑制剂
WO2018102552A1 (en) 2016-11-30 2018-06-07 Case Western Reserve University Combinations of 15-pgdh inhibitors with corcosteroids and/or tnf inhibitors and uses thereof
WO2018145080A1 (en) 2017-02-06 2018-08-09 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
CA3120858A1 (en) 2018-11-21 2020-05-28 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
MX2022014637A (es) 2020-05-20 2023-03-03 Rodeo Therapeutics Corp Composiciones y metodos para modular la actividad de deshidrogenasas de cadena corta.
CN112933100B (zh) * 2021-04-27 2022-06-24 中国人民解放军空军军医大学 去甲泽拉木醛在白癜风药物上的应用及其软膏

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
EP0302147A1 (en) * 1987-08-03 1989-02-08 The Procter & Gamble Company Topical tanning compositions
FR2623716B1 (fr) * 1987-11-27 1991-04-05 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la tyrosine ou un derive de tyrosine et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite pigmentante, l'incorporant
US5352440A (en) * 1988-03-30 1994-10-04 Trustees Of Boston University Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
DE4124693A1 (de) * 1991-07-22 1993-01-28 Schering Ag Carbacyclinderivate als mittel zur behandlung von vitiligo

Also Published As

Publication number Publication date
EP0724425A1 (en) 1996-08-07
AU8008694A (en) 1995-05-08
JPH09504021A (ja) 1997-04-22
WO1995011003A1 (en) 1995-04-27
CA2174655A1 (en) 1995-04-27

Similar Documents

Publication Publication Date Title
SE9303444D0 (sv) New use of prostaglandins
ES2164877T3 (es) Reduccion del crecimiento del pelo.
CA2148652A1 (fr) Utilisation d'un antagoniste de substance p dans une composition cosmetique et composition obtenue
CA2135575A1 (fr) Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable
DE60115618D1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
GT199800197AA (es) Proceso para la sintesis de 1,3-dioles
DE69532167D1 (de) Inhibitierung des haarwuchses
MX9804221A (es) Reduccion del crecimiento del vello.
DE3172264D1 (en) Pre-shampoo type hair treatment composition
BR9306683A (pt) Adesivo proteináceo curado com aldeído
DE69505651T2 (de) Hemmen von haarwuchs
NO971568D0 (no) Analoger av keratinocyttvekstfaktor
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
AU604418B2 (en) Cosmetic composition
ATE168988T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
ES2121463T3 (es) Uso de procisteina como agente blanqueante de la piel.
DE69013972T2 (de) Kosmetische Zusammensetzung.
AU3191889A (en) 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
ES2088682T3 (es) Agente bronceador de la piel.
ATE258926T1 (de) Verfahren zur herstellung von ranitidin
DE69733316D1 (de) Herstellung von 3-fluoroxindolderivaten
AU5217790A (en) 2-alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
AU666109C (en) Combination of dihydroxyacetone and of disubstituted indole derivatives for imparting to the skin a colour similar to natural tanning, process and colouring agents